WFM
SLXP

Wilmington Funds Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Wilmington Funds Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$1.11M Buy
8,992
+1,000
+13% +$111K 0.11% 189
2014
Q1 		$828K Sell
7,992
-2,348
-23% -$240K 0.09% 236
2013
Q4 		$930K Sell
10,340
-2,088
-17% -$167K 0.09% 249
2013
Q3 		$831K Hold
12,428
– – 0.08% 255
2013
Q2 		$822K Buy
+12,428
New +$711K 0.08% 255

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Funds Management's SLXP Position: Q2 2014 in Review

Wilmington Funds Management increased its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 13% in Q2 2014, buying an estimated $111K and bringing the position to 8,992 shares worth $1.11M. The position accounts for 0.11% of the portfolio, ranked #189.

Wilmington Funds Management first reported a position in SLXP in Q2 2013 and has held it in 5 quarters since. 308 funds tracked by Wall St. Rank hold SLXP as of Q2 2014.

  • Wilmington Funds Management held 8,992 shares of SALIX PHARMACEUTICALS LTD DEL worth $1.11M as of Q2 2014.
  • Wilmington Funds Management bought 1,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2014, an estimated $111K.
  • SALIX PHARMACEUTICALS LTD DEL made up 0.11% of Wilmington Funds Management's portfolio in Q2 2014, its #189 holding.
  • Wilmington Funds Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and has held it in 5 quarters since.
  • 308 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.